Greenwich LifeSciences, Inc.

US$15.17As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:GLSIHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR 21.59%
Div yield —
ROE (986.32%)
Biotechnology
Beta (5Y) 1.55
PE TTM —
TSR TTM 64.71%
Mkt cap US$222.7M
ROIC (621.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$17
14.29%
466.15%
Hold 12|4|8|9|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.35
0.36
0.38
0.39
10.32%
8.94%
11.99%
11.21%
Revenue$M
11.76
11.94
12.34
12.71
5.73%
5.67%
8.95%
7.54%
Peers (US$222.7M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.157
(0.052)
(0.048)
EBIT/Intx
1.492
1.147
0.750
Own earn%
45.34
175.17
177.18
Sh yield%
35.91
36.56
36.59
Owners
Insiders/Inst%
9.84
82.01
Short interest%
3.41
SBC / revenue%
4.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
1–7
$1 testx
—
Incr. ROIC%
9